

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in pulmonary arterial hypertension | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/7-1128/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/7-1128" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in pulmonary arterial hypertension" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in pulmonary arterial hypertension.">
            <meta name="og:description" content="Read the latest article version by Martin R. Wilkins, Jurjan Aman, Lars Harbaum, Anna Ulrich, John Wharton, Christopher J. Rhodes, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="16313">
            <meta name="article-id" content="14984">
            <meta name="dc.title" content="Recent advances in pulmonary arterial hypertension">
            <meta name="dc.description" content="Pulmonary arterial hypertension (PAH) is a rare disorder with a high mortality rate. Treatment options have improved in the last 20 years, but patients still die prematurely of right heart failure. Though rare, it is heterogeneous at the genetic and molecular level, and understanding and exploiting this is key to the development of more effective treatments. BMPR2 , encoding bone morphogenetic receptor type 2, is the most commonly affected gene in both familial and non-familial PAH, but rare mutations have been identified in other genes. Transcriptomic, proteomic, and metabolomic studies looking for endophenotypes are under way. There is no shortage of candidate new drug targets for PAH, but the selection and prioritisation of these are challenges for the research community.">
            <meta name="dc.subject" content="pulmonary hypertension, BMPR2, bone morphogenetic receptor type 2, new drug targets">
            <meta name="dc.creator" content="Wilkins, Martin R.">
            <meta name="dc.creator" content="Aman, Jurjan">
            <meta name="dc.creator" content="Harbaum, Lars">
            <meta name="dc.creator" content="Ulrich, Anna">
            <meta name="dc.creator" content="Wharton, John">
            <meta name="dc.creator" content="Rhodes, Christopher J.">
            <meta name="dc.date" content="2018/07/24">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.14984.1">
            <meta name="dc.source" content="F1000Research 2018 7:1128">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="pulmonary hypertension">
            <meta name="prism.keyword" content="BMPR2">
            <meta name="prism.keyword" content="bone morphogenetic receptor type 2">
            <meta name="prism.keyword" content="new drug targets">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2018/07/24">
            <meta name="prism.volume" content="7">
            <meta name="prism.number" content="1128">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.14984.1">
            <meta name="prism.url" content="https://f1000research.com/articles/7-1128">
            <meta name="citation_title" content="Recent advances in pulmonary arterial hypertension">
            <meta name="citation_abstract" content="Pulmonary arterial hypertension (PAH) is a rare disorder with a high mortality rate. Treatment options have improved in the last 20 years, but patients still die prematurely of right heart failure. Though rare, it is heterogeneous at the genetic and molecular level, and understanding and exploiting this is key to the development of more effective treatments. BMPR2 , encoding bone morphogenetic receptor type 2, is the most commonly affected gene in both familial and non-familial PAH, but rare mutations have been identified in other genes. Transcriptomic, proteomic, and metabolomic studies looking for endophenotypes are under way. There is no shortage of candidate new drug targets for PAH, but the selection and prioritisation of these are challenges for the research community.">
            <meta name="citation_description" content="Pulmonary arterial hypertension (PAH) is a rare disorder with a high mortality rate. Treatment options have improved in the last 20 years, but patients still die prematurely of right heart failure. Though rare, it is heterogeneous at the genetic and molecular level, and understanding and exploiting this is key to the development of more effective treatments. BMPR2 , encoding bone morphogenetic receptor type 2, is the most commonly affected gene in both familial and non-familial PAH, but rare mutations have been identified in other genes. Transcriptomic, proteomic, and metabolomic studies looking for endophenotypes are under way. There is no shortage of candidate new drug targets for PAH, but the selection and prioritisation of these are challenges for the research community.">
            <meta name="citation_keywords" content="pulmonary hypertension, BMPR2, bone morphogenetic receptor type 2, new drug targets">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Martin R. Wilkins">
            <meta name="citation_author_institution" content="Department of Medicine, Imperial College London, London, UK">
            <meta name="citation_author" content="Jurjan Aman">
            <meta name="citation_author_institution" content="Department of Medicine, Imperial College London, London, UK">
            <meta name="citation_author" content="Lars Harbaum">
            <meta name="citation_author_institution" content="Department of Medicine, Imperial College London, London, UK">
            <meta name="citation_author" content="Anna Ulrich">
            <meta name="citation_author_institution" content="Department of Medicine, Imperial College London, London, UK">
            <meta name="citation_author" content="John Wharton">
            <meta name="citation_author_institution" content="Department of Medicine, Imperial College London, London, UK">
            <meta name="citation_author" content="Christopher J. Rhodes">
            <meta name="citation_author_institution" content="Department of Medicine, Imperial College London, London, UK">
            <meta name="citation_publication_date" content="2018/07/24">
            <meta name="citation_volume" content="7">
            <meta name="citation_publication_number" content="1128">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.14984.1">
            <meta name="citation_firstpage" content="1128">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/7-1128/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/7-1128.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=16313 /> <input type=hidden id=articleId name=articleId value=14984 /> <input type=hidden id=xmlUrl value="/articles/7-1128/v1/xml"/> <input type=hidden id=xmlFileName value="-7-1128-v1.xml"> <input type=hidden id=article_uuid value=9ed08389-bb82-4d96-924c-47a8f19c2d0b /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in pulmonary arterial hypertension"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.14984.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.14984.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/7-1128"
  },
  "headline": "Recent advances in pulmonary arterial hypertension",
  "datePublished": "2018-07-24T16:21:11",
  "dateModified": "2018-07-24T16:21:11",
  "author": [
    {
      "@type": "Person",
      "name": "Martin R. Wilkins"
    },    {
      "@type": "Person",
      "name": "Jurjan Aman"
    },    {
      "@type": "Person",
      "name": "Lars Harbaum"
    },    {
      "@type": "Person",
      "name": "Anna Ulrich"
    },    {
      "@type": "Person",
      "name": "John Wharton"
    },    {
      "@type": "Person",
      "name": "Christopher J. Rhodes"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Pulmonary arterial hypertension (PAH) is a rare disorder with a high mortality rate. Treatment options have improved in the last 20 years, but patients still die prematurely of right heart failure. Though rare, it is heterogeneous at the genetic and molecular level, and understanding and exploiting this is key to the development of more effective treatments. BMPR2, encoding bone morphogenetic receptor type 2, is the most commonly affected gene in both familial and non-familial PAH, but rare mutations have been identified in other genes. Transcriptomic, proteomic, and metabolomic studies looking for endophenotypes are under way. There is no shortage of candidate new drug targets for PAH, but the selection and prioritisation of these are challenges for the research community."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/7-1128",
            "name": "Recent advances in pulmonary arterial hypertension"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in pulmonary arterial hypertension </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=16313 data-id=14984 data-downloads="" data-views="" data-scholar="10.12688/f1000research.14984.1" data-recommended="" data-doi="10.12688/f1000research.14984.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/7-1128/v1/pdf?article_uuid=9ed08389-bb82-4d96-924c-47a8f19c2d0b" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-14984-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-14984-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-14984-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">Wilkins MR, Aman J, Harbaum L <em>et al.</em> Recent advances in pulmonary arterial hypertension [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1128 (<a class=new-orange href="https://doi.org/10.12688/f1000research.14984.1" target=_blank>https://doi.org/10.12688/f1000research.14984.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-14984-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=14984 id=track-article-signin-14984 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/14984?target=/articles/7-1128">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=16313 /> <input name=articleId type=hidden value=14984 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in pulmonary arterial hypertension</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class=""><a href="mailto:m.wilkins@imperial.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Martin R. Wilkins</span></a><a href="https://orcid.org/0000-0003-3926-1171" target=_blank id=author-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-3926-1171</div>,&nbsp;</span><span class="">Jurjan Aman,&nbsp;</span><span class="">Lars Harbaum,&nbsp;</span><span class="">Anna Ulrich,&nbsp;</span><span class="">John Wharton<a href="https://orcid.org/0000-0001-8110-2575" target=_blank id=author-orcid-4><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-4><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-8110-2575</div>,&nbsp;</span><span class="">Christopher J. Rhodes</span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class=""><a href="mailto:m.wilkins@imperial.ac.uk" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Martin R. Wilkins</span></a><a href="http://orcid.org/0000-0003-3926-1171" target=_blank id=mauthor-orcid-0><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-0><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0003-3926-1171</div>,&nbsp;</span><span class="">Jurjan Aman,&nbsp;</span><a href="#" class=article-page-expand-authors>[...]&nbsp;</a><span class=article-page-hidden-authors>Lars Harbaum,&nbsp;</span><span class=article-page-hidden-authors>Anna Ulrich,&nbsp;</span><span class="">John Wharton<a href="http://orcid.org/0000-0001-8110-2575" target=_blank id=mauthor-orcid-4><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-4><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0001-8110-2575</div>,&nbsp;</span><span class="">Christopher J. Rhodes</span><span class="author-display-control article-page-expand-authors f1r-icon icon-20_plus_big"></span><span class="author-display-control article-page-hidden-authors f1r-icon icon-12_minus_big"></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 24 Jul 2018 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.14984.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Medicine, Imperial College London, London, UK<br/> <p> <div class=margin-bottom> Martin R. Wilkins <br/> <span>Roles: </span> Writing  Original Draft Preparation </div> <div class=margin-bottom> Jurjan Aman <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> Lars Harbaum <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> Anna Ulrich <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> John Wharton <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> Christopher J. Rhodes <br/> <span>Roles: </span> Writing  Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=36797-36257></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=36796-36256></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Pulmonary arterial hypertension (PAH) is a rare disorder with a high mortality rate. Treatment options have improved in the last 20 years, but patients still die prematurely of right heart failure. Though rare, it is heterogeneous at the genetic and molecular level, and understanding and exploiting this is key to the development of more effective treatments. <i>BMPR2</i>, encoding bone morphogenetic receptor type 2, is the most commonly affected gene in both familial and non-familial PAH, but rare mutations have been identified in other genes. Transcriptomic, proteomic, and metabolomic studies looking for endophenotypes are under way. There is no shortage of candidate new drug targets for PAH, but the selection and prioritisation of these are challenges for the research community. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> pulmonary hypertension, BMPR2, bone morphogenetic receptor type 2, new drug targets </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Martin R. Wilkins (<a href="mailto:m.wilkins@imperial.ac.uk">m.wilkins@imperial.ac.uk</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Martin R. Wilkins </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> Martin R. Wilkins, John Wharton, and Christopher Rhodes received advisory board funding from Actelion. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> This article was supported by funding from the British Heart Foundation. <br/> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp;  2018 Wilkins MR <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> Wilkins MR, Aman J, Harbaum L <em>et al.</em> Recent advances in pulmonary arterial hypertension [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1128 (<a href="https://doi.org/10.12688/f1000research.14984.1" target=_blank>https://doi.org/10.12688/f1000research.14984.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 24 Jul 2018, <b>7</b>(F1000 Faculty Rev):1128 (<a href="https://doi.org/10.12688/f1000research.14984.1" target=_blank>https://doi.org/10.12688/f1000research.14984.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 24 Jul 2018, <b>7</b>(F1000 Faculty Rev):1128 (<a href="https://doi.org/10.12688/f1000research.14984.1" target=_blank>https://doi.org/10.12688/f1000research.14984.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d31667e223>Introduction</h2><p class="" id=d31667e226>The normal adult pulmonary circulation, in contrast to the systemic circulation, is a low-pressure, low-resistance vascular bed. Pulmonary hypertension (PH) is diagnosed when the resting mean pulmonary artery pressure (mPAP) is at least 25 mmHg and is classified into five main subgroups based on clinical and haemodynamic criteria<sup><a href="#ref-1">1</a></sup>. It leads to an increased workload for the right ventricle, which, if it fails to hypertrophy and adapt, can result in premature death.</p><p class="" id=d31667e233>PH is not uncommon in left heart failure, in which there is an increasing appreciation of a gradation of risk such that even borderline elevation of mPAP contributes to mortality<sup><a href="#ref-2">2</a></sup>. Pulmonary arterial hypertension (PAH) occurs less frequentlyit has a reported incidence of 1.1 to 17.6 per million adults per year and a prevalence of 6.6 to 26.0 per million adults<sup><a href="#ref-1">1</a></sup> and is diagnosed when the elevated mPAP is attributed to pre-capillary resistance to pulmonary blood flow, in the absence of airway or parenchymal lung diseases, or chronic thromboembolism<sup><a href="#ref-1">1</a>,<a href="#ref-3">3</a></sup>. PAH is clinically heterogeneous, comprising patients presenting with PAH with no obvious cause (termed as idiopathic PAH [IPAH]), heritable PAH, drug-induced PAH, and PAH with associated congenital heart disease, connective tissue disease, HIV, portal hypertension or schistosomiasis. Histology at post-mortem or lung transplantation reveals marked pulmonary arterial remodelling due to vascular cell proliferation encroaching on the vascular lumen (<a href="#f1">Figure 1</a>).</p><a name=f1 class=n-a></a><div class="fig panel clearfix"><a target=_blank href="https://f1000researchdata.s3.amazonaws.com/manuscripts/16313/1be2be71-d3ce-4877-ab80-b6a6f61de85b_figure1.gif"><img alt="1be2be71-d3ce-4877-ab80-b6a6f61de85b_figure1.gif" src="https://f1000researchdata.s3.amazonaws.com/manuscripts/16313/1be2be71-d3ce-4877-ab80-b6a6f61de85b_figure1.gif"></a><div class=caption><h3>Figure 1. Vascular remodelling in pulmonary arterial hypertension.</h3><p id=d31667e264>Haematoxylin-and-eosin staining showing (<b>A</b>) neointimal proliferation (double arrow) in an elastic pulmonary artery, (<b>B</b>) medial hypertrophy and neointimal proliferation leading to occlusion of the vessel lumen (arrows) in muscular pulmonary arteries, and (<b>C</b>) a plexiform lesion, comprising a plexus of capillary-like channels, in a patient with plexogenic arteriopathy.</p></div></div><p class="" id=d31667e280>Even in the modern era, with licensed medication in four drug classes, annual mortality from PAH remains high, at about 10% per year<sup><a href="#ref-1">1</a></sup>. The past two decades have seen a concentrated effort from academia and industry to better understand PAH and improve treatment. The limitations of animal models<sup><a href="#ref-4">4</a></sup> have emphasised the importance of patient-orientated studies, and international collaboration is required to bring together well-phenotyped cohorts of patients. Here, we summarise the progress that is being made from these efforts.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d31667e294>Genetics</h2><p class="" id=d31667e297>Genetic studies have focused on IPAH, heritable PAH, and drug-induced PAH. Pathogenic variants in <i>BMPR2</i> (encoding bone morphogenetic receptor 2), first reported in 2000<sup><a href="#ref-5">5</a>,<a href="#ref-6">6</a></sup>, are found in up to 80% of patients with a clinical diagnosis and a family history of PAH and 15% of patients with IPAH and no known family history<sup><a href="#ref-7">7</a></sup>. Mutations in <i>BMPR2</i> increase susceptibility to PAH (lifetime penetrance is 20%) and are associated with an earlier age of onset of PH and a worse prognosis<sup><a href="#ref-8">8</a></sup>. In the past 18 years, family studies, isolated cases, small case series, and a recent genome-wide case-control analysis of patients in the National Institute for Health Research BioResource (NIHRBR) Rare Diseases study<sup><a href="#ref-7">7</a></sup> have linked at least 10 other genes to PAH (<a href="#T1">Table 1</a>). Some, such as <i>ACVRL1</i>, <i>ENG</i>, <i>SMAD9</i>, and <i>GDF2</i>, encode proteins in the transforming growth factor-beta (TGF) superfamily and emphasise the significance of this signalling pathway in pulmonary vascular homeostasis. Others, such as <i>KCNK3</i><sup><a href="#ref-9">9</a></sup>, <i>TBX4</i><sup><a href="#ref-10">10</a></sup>, and newly identified genes <i>ATP13A3</i>, <i>AQP1</i>, and <i>SOX17</i><sup><a href="#ref-7">7</a></sup>, point to genetic heterogeneity in PAH and novel pathways for therapeutic intervention.</p><a name=T1 class=n-a></a><div class="table-wrap panel clearfix"><div class=caption><h3>Table 1. Genes containing rare variants associated with pulmonary arterial hypertension.</h3></div><table xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class=article-table frame=below><a name=d31667e378 class=n-a></a><thead><a name=d31667e380 class=n-a></a><tr><a name=d31667e382 class=n-a></a><th align=left colspan=1 rowspan=1 valign=top><a name=d31667e384 class=n-a></a>Code</th><th align=left colspan=1 rowspan=1 valign=top><a name=d31667e387 class=n-a></a>Name</th></tr></thead><tbody><a name=d31667e392 class=n-a></a><tr><a name=d31667e394 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d31667e396 class=n-a></a><i>BMPR2</i></td><td align=left colspan=1 rowspan=1 valign=top><a name=d31667e400 class=n-a></a>Bone morphogenetic protein receptor type 2</td></tr><tr><a name=d31667e404 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d31667e406 class=n-a></a><i>ACVRL1</i></td><td align=left colspan=1 rowspan=1 valign=top><a name=d31667e410 class=n-a></a>Activin A receptor like type 1</td></tr><tr><a name=d31667e414 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d31667e416 class=n-a></a><i>ENG</i></td><td align=left colspan=1 rowspan=1 valign=top><a name=d31667e420 class=n-a></a>Endoglin</td></tr><tr><a name=d31667e424 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d31667e426 class=n-a></a><i>SMAD9</i></td><td align=left colspan=1 rowspan=1 valign=top><a name=d31667e430 class=n-a></a>SMAD family member 9</td></tr><tr><a name=d31667e434 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d31667e436 class=n-a></a><i>KCNK3</i></td><td align=left colspan=1 rowspan=1 valign=top><a name=d31667e440 class=n-a></a>Potassium two pore domain channel subfamily K member 3</td></tr><tr><a name=d31667e445 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d31667e447 class=n-a></a><i>TBX4</i></td><td align=left colspan=1 rowspan=1 valign=top><a name=d31667e451 class=n-a></a>T-box 4</td></tr><tr><a name=d31667e455 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d31667e457 class=n-a></a><i>GDF2</i></td><td align=left colspan=1 rowspan=1 valign=top><a name=d31667e461 class=n-a></a>Growth differentiation factor 2 (or bone morphogenetic protein 9)</td></tr><tr><a name=d31667e465 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d31667e467 class=n-a></a><i>ATP13A3</i></td><td align=left colspan=1 rowspan=1 valign=top><a name=d31667e471 class=n-a></a>ATPase 13A3</td></tr><tr><a name=d31667e475 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d31667e477 class=n-a></a><i>AQP1</i></td><td align=left colspan=1 rowspan=1 valign=top><a name=d31667e481 class=n-a></a>Aquaporin 1</td></tr><tr><a name=d31667e485 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d31667e487 class=n-a></a><i>SOX17</i></td><td align=left colspan=1 rowspan=1 valign=top><a name=d31667e491 class=n-a></a>SRY-box 17</td></tr><tr><a name=d31667e495 class=n-a></a><td align=left colspan=1 rowspan=1 valign=top><a name=d31667e497 class=n-a></a><i>EIF2AK4</i><sup><a href="#FN1">a</a></sup></td><td align=left colspan=1 rowspan=1 valign=top><a name=d31667e504 class=n-a></a>Eukaryotic translation initiation factor 2 alpha kinase 4</td></tr></tbody></table><div class=table-wrap-foot><div class=footnote><a name=d31667e512 class=n-a></a><p id=FN1> Rare causal variants identified by family studies and whole genome sequencing case-control analyses<sup><a href="#ref-6">6</a></sup>. <sup>a</sup><i>EIF2AK4</i> mutations associated with pulmonary veno-occlusive disease and pulmonary capillary haemangiomatosis<sup><a href="#ref-10">10</a></sup>.</p></div></div></div><p class="" id=d31667e533>The UK NIHRBR study, which has sequenced over 14,000 whole genomes, including 1,048 cases with a clinical diagnosis of IPAH, heritable PAH, or drug-associated PAH and 6,385 non-PAH controls of European ancestry<sup><a href="#ref-7">7</a></sup>, has offered powerful insight into the genetic architecture of clinical PAH. An early observation is that 1% of patients diagnosed with IPAH in the UK cohort have biallelic mutations in <i>EIF2AK4</i>, a gene associated with pulmonary veno-occlusive disease (PVOD)<sup><a href="#ref-11">11</a></sup>. As patients with PVOD have a poorer prognosis and treatment response, this example illustrates the relevance of genetics for accurate subclassification of patients with PAH, and genetic testing for <i>EIF2AK4</i> should be considered in patients presenting with IPAH. Further studies of larger cohorts will be needed to identify other rare causative mutations. Given the rarity of the disorder, international collaboration will be essential to determine the contribution of common genetic variation to disease risk and outcomes in PAH.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d31667e553>Molecular signatures of pulmonary arterial hypertension</h2><p class="" id=d31667e556>It is accepted that the current clinical classification of PAH is unsatisfactory, from the point of view of both diagnosis and developing new drugs. Genetics coupled with deep molecular phenotyping offers the hope of defining the key drivers of PAH and new drug targets, opening up the possibility of more personalised medicine. The associated National PAH Cohort Study (<a target=xrefwindow href="http://www.ipahcohort.com" id=d31667e558>http://www.ipahcohort.com</a>) is facilitating the collection of biological samples from PAH patients across the UK and is beginning to provide deep phenotyping data, such as metabolomics and proteomics, which can be cross-referenced with the genetic data provided by the NIHRBR effort<sup><a href="#ref-12">12</a>,<a href="#ref-13">13</a></sup>.</p><p class="" id=d31667e569>A subgroup of patients with PAH, less than 10%, respond well to calcium channel blockers, suggesting that this pharmacological phenotype should have a distinct molecular signature. In support of this, a transcriptomic signature has been reported in a small group of patients which requires further prospective validation<sup><a href="#ref-14">14</a></sup>. Responders to calcium channel blockers have also been demonstrated to have metabolic profiles more similar to those of healthy volunteers than PAH patients who do not respond<sup><a href="#ref-13">13</a></sup>.</p><p class="" id=d31667e580>High-throughput technologies, such as that provided by aptamer-based assays, nuclear magnetic resonance, and mass spectroscopy, have been applied to plasma samples and used to risk-stratify patients<sup><a href="#ref-12">12</a>,<a href="#ref-13">13</a></sup>. The prognostic panels developed from this approach may add valuable information to clinical assessment. For example, a nine-protein panel was shown to improve risk stratification in combination with either N-terminal pro-brain natriuretic peptide (NT-proBNP) or the REVEAL (Registry to EValuate Early And Long-term PAH) registry risk equation, an equation built from clinical assessments and comorbidities of patients<sup><a href="#ref-12">12</a>,<a href="#ref-15">15</a></sup>. The advantage of a panel of circulating biomarkers is that they are more objective than functional class assessment and more accessible than imaging, and the combination of molecules reporting on different pathologies (for example, proliferation, inflammation, coagulation, and metabolic dysfunction) provides greater detail than a single biomarker (for example, brain natriuretic peptide).</p><p class="" id=d31667e597>But the real power of these techniques lies in their potential for identifying important and therapeutically relevant subgroups of patients presenting in the clinic. A US National Heart, Lung, and Blood Institute-funded initiative is looking to explore this. The PVDOMICS (Pulmonary Vascular Disease Phenomics Program) consortium seeks to redefine pulmonary hypertension through pulmonary vascular disease phenomics<sup><a href="#ref-16">16</a></sup>. The aim is to enrol 1,500 participants with PH and healthy comparators for comprehensive clinical and omic analyses. Recruitment has begun and an analysis plan has been outlined (ClinicalTrials.gov Identifier: NCT02980887). The challenge of data integration is not to be underestimated, but if successful it will provide the basis for a molecular classification of PH and biologically important insights.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d31667e607>New drugs</h2><p class="" id=d31667e610>The current treatments for PAH come from four drug classes (prostanoid analogues, endothelin receptor antagonists, phosphodiesterase type 5 inhibitors, and soluble guanylate cyclase stimulators) that act to address endothelial dysfunction and reduce vasomotor tone. They provide symptom relief and improve functional capacity, but there is limited evidence that these drugs arrest the course of PAH and prolong the survival of patients. To do that, a drug will need to at least support right ventricular function and, better still, reverse the remodelling of pulmonary arteries. There is no shortage of potential new drug targets for PAH.</p><div class=section><a name=d31667e613 class=n-a></a><h3 class=section-title>Targets from genetics</h3><p class="" id=d31667e618>Impaired BMPR2 signalling creates an imbalance in TGF/BMP signalling favouring TGF and may underlie vascular remodelling in PAH patients with and without <i>BMPR2</i> mutations. A number of therapeutic strategies have been proposed, beyond the aspiration of gene therapy, and include pharmacological approaches, such as chloroquine (to prevent lysosomal degradation of the BMPR2)<sup><a href="#ref-17">17</a></sup>, ataluren (to read through missense mutations), and increasing BMP9 levels<sup><a href="#ref-18">18</a></sup>. To date, the only treatment that has been used to target <i>BMPR2</i> signalling in clinical trials is tacrolimus. This drug binds and removes FKBP12 from all three BMP type 1 receptors and activates BMPR2-mediated signalling even in the absence of exogenous ligand and <i>BMPR2</i>. Although some patients responded with a pronounced increase in <i>BMPR2</i> expression as well as improvement in 6-minute walk distance (6MWD) and serological and echocardiographic parameters of heart failure, the changes were not observed across all patients<sup><a href="#ref-19">19</a></sup>. An alternative approach is to inhibit TGF activity by using a novel activin-receptor fusion protein (sotatercept) that competitively binds and neutralises TGF-superfamily ligands<sup><a href="#ref-20">20</a></sup>. This approach is progressing to clinical trials, but the effect of the rise in haematocrit that accompanies this therapy needs to be carefully monitored and understood.</p></div><div class=section><a name=d31667e651 class=n-a></a><h3 class=section-title>Growth factors</h3><p class="" id=d31667e656>Much has been made of the similarities between the dysregulated growth of vascular cells and that of tumour cells, leading to interest in repurposing drugs from oncology. Studies with the tyrosine kinase receptor inhibitor imatinib have led the field. In addition to inhibiting the bcr-abl tyrosine kinase, imatinib inhibits platelet-derived growth factor (PDGF) receptor- and - and c-KIT. PDGF is a trophic factor in vascular cells, and PAH lung shows increased expression of PDGF receptors<sup><a href="#ref-21">21</a></sup>. A phase 3 trial reported an increase in mean placebo-corrected treatment effect on 6MWD of 32 m and a reduction in pulmonary vascular resistance by 379 dynescm<sup>5</sup><sup><a href="#ref-22">22</a></sup>. But there was no improvement in time to clinical worsening, and serious adverse events and discontinuations were more frequent with imatinib. Of particular concern was subdural hematoma, which occurred in eight patients receiving imatinib and anticoagulation. Further development of imatinib as a treatment has halted, but there remains interest in understanding the characteristics of patients who appear to derive considerable benefit. The ability to identify potential responders, coupled with avoiding concomitant anticoagulation, would help the argument to revisit imatinib as a treatment. However, there remains concern over toxicity, as other tyrosine kinase inhibitors have fared less well and dasatinib use for other indications is associated with the development of PH on rare occasions<sup><a href="#ref-23">23</a>,<a href="#ref-24">24</a></sup>.</p><p class="" id=d31667e676>There is an active interest in elastase inhibitors, which have been shown to prevent and reverse experimental PH<sup><a href="#ref-25">25</a>,<a href="#ref-26">26</a></sup>. Elafin, an endogenously produced low-molecular-weight elastase inhibitor, induces apoptosis in human pulmonary arterial smooth muscle cells and decreases neointimal lesions in lung organ culture. Augmentation of BMPR2 signalling, dependent upon stabilisation of caveolin-1 in the cell membrane, has also been implicated as a mechanism of action<sup><a href="#ref-26">26</a></sup>.</p></div><div class=section><a name=d31667e691 class=n-a></a><h3 class=section-title>Metabolism</h3><p class="" id=d31667e696>The metabolic theory of PAH is based on the observation that proliferating cells switch cell metabolism from oxidative phosphorylation to glycolysis for ATP production<sup><a href="#ref-27">27</a></sup>. Increased expression of pyruvate dehydrogenase kinase (PDK), which inhibits pyruvate dehydrogenase, is one factor underlying this switch, but other PDK-independent factors (for example, variants reducing the function of SERT3 or UCP2 that predict reduced protein function) may also contribute<sup><a href="#ref-28">28</a>,<a href="#ref-29">29</a></sup> and indeed impair the clinical response to inhibition of PDK by dichloroacetate (DCA)<sup><a href="#ref-30">30</a></sup>. A 16-week study of DCA treatment in PAH showed a reduction in pulmonary artery pressure alongside a reduction in lung parenchymal glucose uptake in genetically susceptible patients<sup><a href="#ref-30">30</a></sup>.</p><p class="" id=d31667e718>Aside from the metabolic perturbation seen in proliferating cells, insulin resistance is common in PAH<sup><a href="#ref-31">31</a></sup>. Although the underlying explanation for this association is not clear, pre-clinical data support further evaluation of repurposing insulin resistance medicines in PAH. These include rosiglitazone<sup><a href="#ref-32">32</a></sup>, metformin<sup><a href="#ref-33">33</a></sup>, and glucagon-like peptide 1 (GLP-1) receptor agonists<sup><a href="#ref-34">34</a></sup>.</p></div><div class=section><a name=d31667e739 class=n-a></a><h3 class=section-title>Oestrogen signalling</h3><p class="" id=d31667e744>Despite disparities in the results of pre-clinical and clinical studies, modulation of oestrogen levels is another potential therapeutic approach for the treatment of PAH<sup><a href="#ref-35">35</a></sup>. A variant in the promoter region of the aromatase gene, which encodes the enzyme responsible for the conversion of androgens to oestrogen, is associated with higher circulating 17b-estradiol (E2) levels and increased risk of PAH in patients with cirrhosis<sup><a href="#ref-36">36</a></sup>. Inhibition of aromatase via anastrozole or metformin therapy also reduced PH and right ventricular hypertrophy in <i>in vivo</i> models of PH<sup><a href="#ref-37">37</a>,<a href="#ref-38">38</a></sup>. These observations have culminated in a randomised clinical trial in 18 patients, where anastrozole (1 mg/day) significantly reduced serum E2 levels and increased 6MWD compared with placebo<sup><a href="#ref-39">39</a></sup>, and a further phase 2 study is in progress (ClinicalTrials.gov Identifier: NCT03229499).</p></div><div class=section><a name=d31667e770 class=n-a></a><h3 class=section-title>Inflammation</h3><p class="" id=d31667e775>Histological studies of PAH lung support the case for inflammation as a pathological driver of PH<sup><a href="#ref-40">40</a></sup>. A clinical trial of the anti-CD20 monoclonal antibody rituximab in PAH associated with connective tissue disease is ongoing (ClinicalTrials.gov Identifier: NCT01086540). Pre-clinical data supporting a role for interleukin-6 (IL-6)<sup><a href="#ref-41">41</a></sup> underpins a trial of tocilizumab in PAH, which has just been completed (ClinicalTrials.gov Identifier: NCT02676947). Autoantibodies have been detected in IPAH that can contribute to worsening of the disease, and the effect of immunoadsorption as an add-on to optimised medical treatment has been explored with some haemodynamic improvement (ClinicalTrials.gov Identifier: NCT01613287). The main concern with immunomodulation is the risk of infection.</p></div><div class=section><a name=d31667e787 class=n-a></a><h3 class=section-title>Oxidative stress</h3><p class="" id=d31667e792>Attempts to reduce oxidative stress in PAH have included inhibition of apoptosis signal-regulating kinase 1 (ASK1) and treatment with bardoxolone methyl. Pharmacological inhibition of ASK1 has demonstrated efficacy in a number of pre-clinical PAH models<sup><a href="#ref-42">42</a></sup>, but a phase 2 clinical trial (ClinicalTrials.gov Identifier: NCT02234141) failed to show clinical benefit.</p><p class="" id=d31667e799>Bardoxolone methyl is an orally available semi-synthetic triterpenoid that induces the nuclear factor erythroid 2-related factor 2 (Nrf2), a transcription factor that regulates antioxidant proteins, and suppresses activation of the pro-inflammatory factor nuclear factor kappa-light-chain-enhancer of activated B cells (NF-B). An initial report from a phase 2 study reported some signals of efficacy, and a phase 3 study is in progress (ClinicalTrials.gov Identifiers: NCT02036970 and NCT03068130). Elamipretide, a small mitochondrially targeted tetrapeptide (D-Arg-dimethylTyr-Lys-Phe-NH2) that is currently in development as a treatment for mitochondrial disease (ClinicalTrials.gov Identifier: NCT02805790) and that appears to reduce the production of toxic reactive oxygen species (ROS) and stabilise cardiolipin, is also of interest in PH<sup><a href="#ref-43">43</a></sup>.</p></div><div class=section><a name=d31667e807 class=n-a></a><h3 class=section-title>Hypoxic stress and iron homeostasis</h3><p class="" id=d31667e812>Hypoxia-inducible factor (HIF) is upregulated in remodelled pulmonary vessels. Selective deletion of either HIF1 or HIF2 offers protection against hypoxia-induced PH in mice<sup><a href="#ref-44">44</a>,<a href="#ref-45">45</a></sup>. Mutations that lead to dysfunctional von HippelLindau (VHL) protein lead to PH in the context of patients with Chuvash polycythemia<sup><a href="#ref-46">46</a></sup>. Iron deficiency in the absence of anaemia is common in PAH and is associated with reduced survival<sup><a href="#ref-47">47</a></sup>. The cause is unclear. It is not explained by inflammation. Oral iron is poorly absorbed by patients with PAH. Two open-label studies of intravenous iron replacement in PAH have reported an improvement in measures of exercise capacity<sup><a href="#ref-48">48</a>,<a href="#ref-49">49</a></sup>. A randomised double-blind study is near completion (ClinicalTrials.gov Identifier: NCT01447628).</p></div><div class=section><a name=d31667e838 class=n-a></a><h3 class=section-title>Serotonin</h3><p class="" id=d31667e843>The 5-HT1B receptor is highly expressed in human pulmonary arteries, has increased expression in patients with PAH, and mediates serotonin-induced vasoconstriction and remodelling<sup><a href="#ref-50">50</a></sup>. The 5-HT2A receptor mediates these effects systemically and so the 5-HT1B effects are pulmonary specific. Both the 5-HT1B receptor and serotonin transporter (SERT) are important in Nox1-derived ROS production and in serotonin-mediated vascular effects in PAH. But, so far, clinical studies evaluating pharmacological manipulation of serotonin activity in PAH have been disappointing. Current interest resides with inhibition of tryptophan hydroxylase 1 (TPH1), the rate-limiting enzyme in serotonin biosynthesis. KAR5585, a prodrug of KAR5417, is a functionally selective inhibitor of TPH1. Dose-dependent inhibition of serum serotonin and its plasma and urinary breakdown product 5-hydroxyindoleacetic acid (5-HIAA) have been demonstrated in healthy volunteers (ClinicalTrials.gov Identifier: NCT02746237). In pre-clinical PAH models, KAR5585 decreased serum, gut, and lung levels of serotonin and 5-HIAA in a dose-dependent manner and significantly reduced pulmonary arterial pressure and pulmonary vessel wall thickness and occlusion<sup><a href="#ref-51">51</a></sup>.</p></div><div class=section><a name=d31667e855 class=n-a></a><h3 class=section-title>Humoral modulation</h3><p class="" id=d31667e860>Pre-clinical data<sup><a href="#ref-52">52</a></sup> and an early clinical study suggest that vasoactive intestinal polypeptide (VIP) may have a beneficial effect in PAH<sup><a href="#ref-53">53</a></sup>. This was not supported by a study of VIP administration by inhalation<sup><a href="#ref-54">54</a></sup>, but further studies addressing the formulation and bioavailability of VIP are recruiting (ClinicalTrials.gov Identifier: NCT03315507).</p><p class="" id=d31667e875>Activation of the sympathetic and reninangiotensin systems in PAH is well recognised. Although benefit from beta-blockers and inhibition of angiotensin-converting enzyme (ACE) and angiotensin II has been documented in the systemic circulation, this cannot be extrapolated to the pulmonary circulation. The debate about inhibition of sympathetic activity in PAH has been around whether it has a pathological as opposed to a compensatory role and whether interference is safe. Observations from small randomised, prospective clinical trials including bisoprolol and carvedilol have reported opposing results concerning safety<sup><a href="#ref-55">55</a>,<a href="#ref-56">56</a></sup>. Therefore, further efforts are still required to clarify the optimal timing, duration, and dosing of beta-blocker therapy in patients with PAH.</p><p class="" id=d31667e885>ACE2 is a homologue of ACE that is insensitive to ACE inhibitors. It converts angiotensin I and angiotensin II to angiotensin-(17), angiotensin-(19), and angiotensin-(15). These peptides have vasculo- and cardio-protective properties. Decreased ACE2 levels and ACE2 autoantibodies have been detected in serum from patients with PAH and have been implicated in contributing to the pathophysiology of PAH<sup><a href="#ref-57">57</a></sup>. Studies of the effect of a purified intravenous formulation of soluble recombinant human ACE 2 (rhACE2; GSK2586881) are under way (ClinicalTrials.gov Identifier: NCT03177603), but a recent open-label pilot study of five PAH patients (ClinicalTrials.gov Identifier: NCT01884051) found that a single infusion of rhACE2 was well-tolerated and was associated with improved pulmonary haemodynamics and reduced markers of oxidant and inflammatory stress<sup><a href="#ref-58">58</a></sup>.</p><p class="" id=d31667e896>Interest in the fibrogenic properties of aldosterone has led to studies of mineralocorticoid receptor antagonism with spironolactone or eplerenone in animal models, which provide evidence of efficacy. Retrospective analysis of data on the addition of spironolactone to targeted PAH treatment with ambrisentan from ARIES 1 and ARIES 2 studies suggests some clinical benefit. Two prospective studies are examining the effect of chronic spironolactone on markers of fibrosis (ClinicalTrials.gov Identifier: NCT01468571) and exercise capacity (ClinicalTrials.gov Identifier: NCT01712620).</p></div><div class=section><a name=d31667e901 class=n-a></a><h3 class=section-title>Epigenetic</h3><p class="" id=d31667e906>Histone deacetylase (HDAC) inhibitors have been reported to produce both benefit<sup><a href="#ref-59">59</a>,<a href="#ref-60">60</a></sup> and harm<sup><a href="#ref-61">61</a></sup> in pre-clinical models of PAH. Of particular concern is cardiotoxicity. There are four classes of HDACs and a number of subtypes. Identifying the HDAC subtype that is relevant and a specific inhibitor is key to unlocking the therapeutic potential of this approach. Indeed, recent pre-clinical studies suggest that HDAC6 is implicated in the development of PAH and selective inhibition represents a new promising target to improve PAH<sup><a href="#ref-62">62</a></sup>. MicroRNAs (miRNAs) have also been shown to reverse as well as prevent PH in animal models<sup><a href="#ref-63">63</a></sup>. As with HDAC inhibitors, the challenge in the first instance is to identify the most relevant miRNA in PAH pathobiology and attention has focused on the miR-143/145 cluster, for example <a href="#ref-64">64</a>,<a href="#ref-65">65</a>.</p></div><div class=section><a name=d31667e936 class=n-a></a><h3 class=section-title>DNA damage</h3><p class="" id=d31667e941>Dysregulation of DNA damage-and-repair mechanisms has been identified as a trigger for disease progression in PAH<sup><a href="#ref-66">66</a></sup>, and inhibition of poly(ADP-ribose) polymerase (PARP) reverses PAH in several animal models<sup><a href="#ref-67">67</a></sup>. A safety study to repurpose olaparib, an orally available PARP inhibitor approved for the treatment of BRCA-related breast cancer, for PAH has been proposed (ClinicalTrials.gov Identifier: NCT03251872).</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d31667e956>Challenges</h2><p class="" id=d31667e959>With these opportunities come challenges. The animal models are not high-fidelity reproductions of the human condition and have a poor track record for predicting efficacy. The clinical trial design template used for the currently approved drugs, which act by reducing vascular tone, is not suitable for the development of drugs that target vascular remodelling. Clinical trials have to compete for a relatively small pool of patients.</p><p class="" id=d31667e962>There is considerable room to improve how we select and prioritise new candidate drugs for evaluation, how we identify suitable patients for each study, how we use creative trial designs for go/no-go decisions, and how we learn from failure. Targets suggested by genetic studies understandably hold pride of place in prioritising candidates to take forward. A variant that is associated with PAH through a biologically plausible pathway (that is, supported by endophenotype data) reduces the risk of failure and provides a biomarker for selecting suitable patients for the clinical study. But we can also learn from studies where human exposure has already taken place. Analysing samples and data from patients according to response can suggest strategies for enrichment (using genetic, proteomic, metabolomic, or other clinical markers) in follow-on studies with patients more likely to respond.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d31667e1 class=n-a></a><h2 class=main-title id=d31915>Competing interests</h2><p class=metadata-entry><a name=d31667e151 class=n-a></a><p id=d31667e152> Martin R. Wilkins, John Wharton, and Christopher Rhodes received advisory board funding from Actelion.</p></p></div><div class=back-section><a name=d31667e1 class=n-a></a><h2 class=main-title id=d31917>Grant information</h2><p>This article was supported by funding from the British Heart Foundation.</p><p> <i>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</i> </p></div><div class=back-section><a name=d31667e969 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d32158>References</h2><div class="section ref-list"><a name=d31667e969 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726219340"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d31667e976 class=n-a></a>Hoeper MM, Humbert M, Souza R, <i> et al.</i>: A global view of pulmonary hypertension. <i>Lancet Respir Med.</i> 2016; <b>4</b>(4): 30622. <a target=xrefwindow id=d31667e987 href="http://www.ncbi.nlm.nih.gov/pubmed/26975810">PubMed Abstract </a> | <a target=xrefwindow id=d31667e990 href="http://dx.doi.org/10.1016/S2213-2600(15)00543-3">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726219340">F1000 Recommendation</a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726144684"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d31667e1003 class=n-a></a>Maron BA, Hess E, Maddox TM, <i> et al.</i>: Association of Borderline Pulmonary Hypertension With Mortality and Hospitalization in a Large Patient Cohort: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program. <i>Circulation.</i> 2016; <b>133</b>(13): 12408. <a target=xrefwindow id=d31667e1014 href="http://www.ncbi.nlm.nih.gov/pubmed/26873944">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1017 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.115.020207">Publisher Full Text </a> | <a target=xrefwindow id=d31667e1021 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4811678">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726144684">F1000 Recommendation</a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a name=d31667e1034 class=n-a></a>Gali N, Humbert M, Vachiery JL, <i> et al.</i>: 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). <i>Eur Heart J.</i> 2016; <b>37</b>(1): 67119. <a target=xrefwindow id=d31667e1045 href="http://www.ncbi.nlm.nih.gov/pubmed/26320113">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1048 href="http://dx.doi.org/10.1093/eurheartj/ehv317">Publisher Full Text </a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d31667e1057 class=n-a></a>Stenmark KR, Meyrick B, Galie N, <i> et al.</i>: Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure. <i>Am J Physiol Lung Cell Mol Physiol.</i> 2009; <b>297</b>(6): L101332. <a target=xrefwindow id=d31667e1068 href="http://www.ncbi.nlm.nih.gov/pubmed/19748998">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1071 href="http://dx.doi.org/10.1152/ajplung.00217.2009">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a name=d31667e1080 class=n-a></a>International PPH Consortium, Lane KB, Machado RD, <i> et al.</i>: Heterozygous germline mutations in <i>BMPR2</i>, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension. <i>Nat Genet.</i> 2000; <b>26</b>(1): 814. <a target=xrefwindow id=d31667e1094 href="http://www.ncbi.nlm.nih.gov/pubmed/10973254">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1098 href="http://dx.doi.org/10.1038/79226">Publisher Full Text </a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d31667e1108 class=n-a></a>Deng Z, Morse JH, Slager SL, <i> et al.</i>: Familial primary pulmonary hypertension (<i>gene PPH1</i>) is caused by mutations in the bone morphogenetic protein receptor-II gene. <i>Am J Hum Genet.</i> 2000; <b>67</b>(3): 73744. <a target=xrefwindow id=d31667e1122 href="http://www.ncbi.nlm.nih.gov/pubmed/10903931">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1126 href="http://dx.doi.org/10.1086/303059">Publisher Full Text </a> | <a target=xrefwindow id=d31667e1129 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1287532">Free Full Text </a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a name=d31667e1138 class=n-a></a>Grf S, Haimel M, Bleda M, <i> et al.</i>: Identification of rare sequence variation underlying heritable pulmonary arterial hypertension. <i>Nat Commun.</i> 2018; <b>9</b>(1): 1416. <a target=xrefwindow id=d31667e1149 href="http://www.ncbi.nlm.nih.gov/pubmed/29650961">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1152 href="http://dx.doi.org/10.1038/s41467-018-03672-4">Publisher Full Text </a> | <a target=xrefwindow id=d31667e1156 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5897357">Free Full Text </a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726091197"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d31667e1165 class=n-a></a>Evans JD, Girerd B, Montani D, <i> et al.</i>: <i>BMPR2</i> mutations and survival in pulmonary arterial hypertension: an individual participant data meta-analysis. <i>Lancet Respir Med.</i> 2016; <b>4</b>(2): 12937. <a target=xrefwindow id=d31667e1179 href="http://www.ncbi.nlm.nih.gov/pubmed/26795434">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1183 href="http://dx.doi.org/10.1016/S2213-2600(15)00544-5">Publisher Full Text </a> | <a target=xrefwindow id=d31667e1186 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4737700">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726091197">F1000 Recommendation</a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718047144"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d31667e1199 class=n-a></a>Ma L, Roman-Campos D, Austin ED, <i> et al.</i>: A novel channelopathy in pulmonary arterial hypertension. <i>N Engl J Med.</i> 2013; <b>369</b>(4): 35161. <a target=xrefwindow id=d31667e1210 href="http://www.ncbi.nlm.nih.gov/pubmed/23883380">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1213 href="http://dx.doi.org/10.1056/NEJMoa1211097">Publisher Full Text </a> | <a target=xrefwindow id=d31667e1217 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3792227">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718047144">F1000 Recommendation</a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a name=d31667e1230 class=n-a></a>Kerstjens-Frederikse WS, Bongers EM, Roofthooft MT, <i> et al.</i>: <i>TBX4</i> mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertension. <i>J Med Genet.</i> 2013; <b>50</b>(8): 5006. <a target=xrefwindow id=d31667e1244 href="http://www.ncbi.nlm.nih.gov/pubmed/23592887">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1248 href="http://dx.doi.org/10.1136/jmedgenet-2012-101152">Publisher Full Text </a> | <a target=xrefwindow id=d31667e1251 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3717587">Free Full Text </a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d31667e1260 class=n-a></a>Hadinnapola C, Bleda M, Haimel M, <i> et al.</i>: Phenotypic Characterization of <i>EIF2AK4</i> Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension. <i>Circulation.</i> 2017; <b>136</b>(21): 202233. <a target=xrefwindow id=d31667e1274 href="http://www.ncbi.nlm.nih.gov/pubmed/28972005">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1278 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.117.028351">Publisher Full Text </a> | <a target=xrefwindow id=d31667e1281 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5700414">Free Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d31667e1291 class=n-a></a>Rhodes CJ, Wharton J, Ghataorhe P, <i> et al.</i>: Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study. <i>Lancet Respir Med.</i> 2017; <b>5</b>(9): 71726. <a target=xrefwindow id=d31667e1302 href="http://www.ncbi.nlm.nih.gov/pubmed/28624389">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1305 href="http://dx.doi.org/10.1016/S2213-2600(17)30161-3">Publisher Full Text </a> | <a target=xrefwindow id=d31667e1309 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5573768">Free Full Text </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a name=d31667e1318 class=n-a></a>Rhodes CJ, Ghataorhe P, Wharton J, <i> et al.</i>: Plasma Metabolomics Implicates Modified Transfer RNAs and Altered Bioenergetics in the Outcomes of Pulmonary Arterial Hypertension. <i>Circulation.</i> 2017; <b>135</b>(5): 46075. <a target=xrefwindow id=d31667e1329 href="http://www.ncbi.nlm.nih.gov/pubmed/27881557">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1332 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.116.024602">Publisher Full Text </a> | <a target=xrefwindow id=d31667e1336 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5287439">Free Full Text </a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/724887090"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d31667e1345 class=n-a></a>Hemnes AR, Trammell AW, Archer SL, <i> et al.</i>: Peripheral blood signature of vasodilator-responsive pulmonary arterial hypertension. <i>Circulation.</i> 2015; <b>131</b>(4): 4019; discussion 409. <a target=xrefwindow id=d31667e1356 href="http://www.ncbi.nlm.nih.gov/pubmed/25361553">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1359 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.114.013317">Publisher Full Text </a> | <a target=xrefwindow id=d31667e1363 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4308423">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/724887090">F1000 Recommendation</a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/8192956"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d31667e1376 class=n-a></a>Benza RL, Miller DP, Gomberg-Maitland M, <i> et al.</i>: Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL). <i>Circulation.</i> 2010; <b>122</b>(2): 16472. <a target=xrefwindow id=d31667e1387 href="http://www.ncbi.nlm.nih.gov/pubmed/20585012">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1390 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.109.898122">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/8192956">F1000 Recommendation</a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a name=d31667e1403 class=n-a></a>Hemnes AR, Beck GJ, Newman JH, <i> et al.</i>: PVDOMICS: A Multi-Center Study to Improve Understanding of Pulmonary Vascular Disease Through Phenomics. <i>Circ Res.</i> 2017; <b>121</b>(10): 11369. <a target=xrefwindow id=d31667e1414 href="http://www.ncbi.nlm.nih.gov/pubmed/29074534">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1417 href="http://dx.doi.org/10.1161/CIRCRESAHA.117.311737">Publisher Full Text </a> | <a target=xrefwindow id=d31667e1421 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5685561">Free Full Text </a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717982332"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d31667e1430 class=n-a></a>Long L, Yang X, Southwood M, <i> et al.</i>: Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor degradation. <i>Circ Res.</i> 2013; <b>112</b>(8): 115970. <a target=xrefwindow id=d31667e1441 href="http://www.ncbi.nlm.nih.gov/pubmed/23446737">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1444 href="http://dx.doi.org/10.1161/CIRCRESAHA.111.300483">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717982332">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725866926"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d31667e1458 class=n-a></a>Morrell NW, Bloch DB, ten Dijke P, <i> et al.</i>: Targeting BMP signalling in cardiovascular disease and anaemia. <i>Nat Rev Cardiol.</i> 2016; <b>13</b>(2): 10620. <a target=xrefwindow id=d31667e1469 href="http://www.ncbi.nlm.nih.gov/pubmed/26461965">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1472 href="http://dx.doi.org/10.1038/nrcardio.2015.156">Publisher Full Text </a> | <a target=xrefwindow id=d31667e1476 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4886232">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725866926">F1000 Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/731115656"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d31667e1489 class=n-a></a>Spiekerkoetter E, Sung YK, Sudheendra D, <i> et al.</i>: Randomised placebo-controlled safety and tolerability trial of FK506 (tacrolimus) for pulmonary arterial hypertension. <i>Eur Respir J.</i> 2017; <b>50</b>(3): pii: 1602449. <a target=xrefwindow id=d31667e1500 href="http://www.ncbi.nlm.nih.gov/pubmed/28893866">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1503 href="http://dx.doi.org/10.1183/13993003.02449-2016">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/731115656">F1000 Recommendation</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d31667e1516 class=n-a></a>Komrokji R, Garcia-Manero G, Ades L, <i> et al.</i>: Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trial. <i>Lancet Haematol.</i> 2018; <b>5</b>(2): e63e72. <a target=xrefwindow id=d31667e1527 href="http://www.ncbi.nlm.nih.gov/pubmed/29331635">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1530 href="http://dx.doi.org/10.1016/S2352-3026(18)30002-4">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a name=d31667e1539 class=n-a></a>Schermuly RT, Dony E, Ghofrani HA, <i> et al.</i>: Reversal of experimental pulmonary hypertension by PDGF inhibition. <i>J Clin Invest.</i> 2005; <b>115</b>(10): 281121. <a target=xrefwindow id=d31667e1550 href="http://www.ncbi.nlm.nih.gov/pubmed/16200212">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1553 href="http://dx.doi.org/10.1172/JCI24838">Publisher Full Text </a> | <a target=xrefwindow id=d31667e1557 href="http://www.ncbi.nlm.nih.gov/pmc/articles/1236676">Free Full Text </a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717978689"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d31667e1566 class=n-a></a>Hoeper MM, Barst RJ, Bourge RC, <i> et al.</i>: Imatinib mesylate as add-on therapy for pulmonary arterial hypertension: results of the randomized IMPRES study. <i>Circulation.</i> 2013; <b>127</b>(10): 112838. <a target=xrefwindow id=d31667e1577 href="http://www.ncbi.nlm.nih.gov/pubmed/23403476">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1580 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.112.000765">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717978689">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d31667e1593 class=n-a></a>Montani D, Bergot E, Gnther S, <i> et al.</i>: Pulmonary arterial hypertension in patients treated by dasatinib. <i>Circulation.</i> 2012; <b>125</b>(17): 212837. <a target=xrefwindow id=d31667e1604 href="http://www.ncbi.nlm.nih.gov/pubmed/22451584">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1607 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.111.079921">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726602961"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d31667e1617 class=n-a></a>Guignabert C, Phan C, Seferian A, <i> et al.</i>: Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertension. <i>J Clin Invest.</i> 2016; <b>126</b>(9): 320718. <a target=xrefwindow id=d31667e1628 href="http://www.ncbi.nlm.nih.gov/pubmed/27482885">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1631 href="http://dx.doi.org/10.1172/JCI86249">Publisher Full Text </a> | <a target=xrefwindow id=d31667e1635 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5004960">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726602961">F1000 Recommendation</a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a name=d31667e1648 class=n-a></a>Kim YM, Haghighat L, Spiekerkoetter E, <i> et al.</i>: Neutrophil elastase is produced by pulmonary artery smooth muscle cells and is linked to neointimal lesions. <i>Am J Pathol.</i> 2011; <b>179</b>(3): 156072. <a target=xrefwindow id=d31667e1659 href="http://www.ncbi.nlm.nih.gov/pubmed/21763677">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1662 href="http://dx.doi.org/10.1016/j.ajpath.2011.05.051">Publisher Full Text </a> | <a target=xrefwindow id=d31667e1666 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3157285">Free Full Text </a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725426701"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d31667e1675 class=n-a></a>Nickel NP, Spiekerkoetter E, Gu M, <i> et al.</i>: Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling. <i>Am J Respir Crit Care Med.</i> 2015; <b>191</b>(11): 127386. <a target=xrefwindow id=d31667e1686 href="http://www.ncbi.nlm.nih.gov/pubmed/25853696">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1689 href="http://dx.doi.org/10.1164/rccm.201412-2291OC">Publisher Full Text </a> | <a target=xrefwindow id=d31667e1693 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4476518">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725426701">F1000 Recommendation</a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d31667e1706 class=n-a></a>Sutendra G, Michelakis ED: The metabolic basis of pulmonary arterial hypertension. <i>Cell Metab.</i> 2014; <b>19</b>(4): 55873. <a target=xrefwindow id=d31667e1714 href="http://www.ncbi.nlm.nih.gov/pubmed/24508506">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1717 href="http://dx.doi.org/10.1016/j.cmet.2014.01.004">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d31667e1726 class=n-a></a>Dromparis P, Paulin R, Sutendra G, <i> et al.</i>: Uncoupling protein 2 deficiency mimics the effects of hypoxia and endoplasmic reticulum stress on mitochondria and triggers pseudohypoxic pulmonary vascular remodeling and pulmonary hypertension. <i>Circ Res.</i> 2013; <b>113</b>(2): 12636. <a target=xrefwindow id=d31667e1737 href="http://www.ncbi.nlm.nih.gov/pubmed/23652801">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1740 href="http://dx.doi.org/10.1161/CIRCRESAHA.112.300699">Publisher Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a name=d31667e1749 class=n-a></a>Paulin R, Dromparis P, Sutendra G, <i> et al.</i>: Sirtuin 3 deficiency is associated with inhibited mitochondrial function and pulmonary arterial hypertension in rodents and humans. <i>Cell Metab.</i> 2014; <b>20</b>(5): 82739. <a target=xrefwindow id=d31667e1760 href="http://www.ncbi.nlm.nih.gov/pubmed/25284742">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1763 href="http://dx.doi.org/10.1016/j.cmet.2014.08.011">Publisher Full Text </a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a name=d31667e1773 class=n-a></a>Michelakis ED, Gurtu V, Webster L, <i> et al.</i>: Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients. <i>Sci Transl Med.</i> 2017; <b>9</b>(413): pii: eaao4583. <a target=xrefwindow id=d31667e1784 href="http://www.ncbi.nlm.nih.gov/pubmed/29070699">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1787 href="http://dx.doi.org/10.1126/scitranslmed.aao4583">Publisher Full Text </a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d31667e1796 class=n-a></a>Pugh ME, Robbins IM, Rice TW, <i> et al.</i>: Unrecognized glucose intolerance is common in pulmonary arterial hypertension. <i>J Heart Lung Transplant.</i> 2011; <b>30</b>(8): 90411. <a target=xrefwindow id=d31667e1807 href="http://www.ncbi.nlm.nih.gov/pubmed/21493097">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1810 href="http://dx.doi.org/10.1016/j.healun.2011.02.016">Publisher Full Text </a> | <a target=xrefwindow id=d31667e1814 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3129440">Free Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d31667e1823 class=n-a></a>Hansmann G, de Jesus Perez VA, Alastalo TP, <i> et al.</i>: An antiproliferative BMP-2/PPARgamma/apoE axis in human and murine SMCs and its role in pulmonary hypertension. <i>J Clin Invest.</i> 2008; <b>118</b>(5): 184657. <a target=xrefwindow id=d31667e1834 href="http://www.ncbi.nlm.nih.gov/pubmed/18382765">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1837 href="http://dx.doi.org/10.1172/JCI32503">Publisher Full Text </a> | <a target=xrefwindow id=d31667e1841 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2276393">Free Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a name=d31667e1850 class=n-a></a>Agard C, Rolli-Derkinderen M, Dumas-de-La-Roque E, <i> et al.</i>: Protective role of the antidiabetic drug metformin against chronic experimental pulmonary hypertension. <i>Br J Pharmacol.</i> 2009; <b>158</b>(5): 128594. <a target=xrefwindow id=d31667e1861 href="http://www.ncbi.nlm.nih.gov/pubmed/19814724">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1864 href="http://dx.doi.org/10.1111/j.1476-5381.2009.00445.x">Publisher Full Text </a> | <a target=xrefwindow id=d31667e1868 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2782337">Free Full Text </a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d31667e1877 class=n-a></a>Lee MY, Tsai KB, Hsu JH, <i> et al.</i>: Liraglutide prevents and reverses monocrotaline-induced pulmonary arterial hypertension by suppressing ET-1 and enhancing eNOS/sGC/PKG pathways. <i>Sci Rep.</i> 2016; <b>6</b>: 31788. <a target=xrefwindow id=d31667e1888 href="http://www.ncbi.nlm.nih.gov/pubmed/27581840">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1891 href="http://dx.doi.org/10.1038/srep31788">Publisher Full Text </a> | <a target=xrefwindow id=d31667e1895 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5007506">Free Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a name=d31667e1904 class=n-a></a>Lahm T, Tuder RM, Petrache I: Progress in solving the sex hormone paradox in pulmonary hypertension. <i>Am J Physiol Lung Cell Mol Physiol.</i> 2014; <b>307</b>(1): L726. <a target=xrefwindow id=d31667e1912 href="http://www.ncbi.nlm.nih.gov/pubmed/24816487">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1915 href="http://dx.doi.org/10.1152/ajplung.00337.2013">Publisher Full Text </a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d31667e1925 class=n-a></a>Roberts KE, Fallon MB, Krowka MJ, <i> et al.</i>: Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease. <i>Am J Respir Crit Care Med.</i> 2009; <b>179</b>(9): 83542. <a target=xrefwindow id=d31667e1936 href="http://www.ncbi.nlm.nih.gov/pubmed/19218192">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1939 href="http://dx.doi.org/10.1164/rccm.200809-1472OC">Publisher Full Text </a> | <a target=xrefwindow id=d31667e1943 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2675568">Free Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a name=d31667e1952 class=n-a></a>Mair KM, Wright AF, Duggan N, <i> et al.</i>: Sex-dependent influence of endogenous estrogen in pulmonary hypertension. <i>Am J Respir Crit Care Med.</i> 2014; <b>190</b>(4): 45667. <a target=xrefwindow id=d31667e1963 href="http://www.ncbi.nlm.nih.gov/pubmed/24956156">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1966 href="http://dx.doi.org/10.1164/rccm.201403-0483OC">Publisher Full Text </a> | <a target=xrefwindow id=d31667e1970 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4214128">Free Full Text </a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d31667e1979 class=n-a></a>Dean A, Nilsen M, Loughlin L, <i> et al.</i>: Metformin Reverses Development of Pulmonary Hypertension via Aromatase Inhibition. <i>Hypertension.</i> 2016; <b>68</b>(2): 44654. <a target=xrefwindow id=d31667e1990 href="http://www.ncbi.nlm.nih.gov/pubmed/27296990">PubMed Abstract </a> | <a target=xrefwindow id=d31667e1993 href="http://dx.doi.org/10.1161/HYPERTENSIONAHA.116.07353">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d31667e2002 class=n-a></a>Kawut SM, Archer-Chicko CL, DeMichele A, <i> et al.</i>: Anastrozole in Pulmonary Arterial Hypertension. A Randomized, Double-Blind, Placebo-controlled Trial. <i>Am J Respir Crit Care Med.</i> 2017; <b>195</b>(3): 3608. <a target=xrefwindow id=d31667e2013 href="http://www.ncbi.nlm.nih.gov/pubmed/27602993">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2016 href="http://dx.doi.org/10.1164/rccm.201605-1024OC">Publisher Full Text </a> | <a target=xrefwindow id=d31667e2020 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5328182">Free Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a name=d31667e2029 class=n-a></a>Perros F, Dorfmller P, Montani D, <i> et al.</i>: Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension. <i>Am J Respir Crit Care Med.</i> 2012; <b>185</b>(3): 31121. <a target=xrefwindow id=d31667e2040 href="http://www.ncbi.nlm.nih.gov/pubmed/22108206">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2043 href="http://dx.doi.org/10.1164/rccm.201105-0927OC">Publisher Full Text </a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/733017996"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d31667e2052 class=n-a></a>Tamura Y, Phan C, Tu L, <i> et al.</i>: Ectopic upregulation of membrane-bound IL6R drives vascular remodeling in pulmonary arterial hypertension. <i>J Clin Invest.</i> 2018; <b>128</b>(5): 195670. <a target=xrefwindow id=d31667e2063 href="http://www.ncbi.nlm.nih.gov/pubmed/29629897">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2066 href="http://dx.doi.org/10.1172/JCI96462">Publisher Full Text </a> | <a target=xrefwindow id=d31667e2070 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5919830">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/733017996">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a name=d31667e2084 class=n-a></a>Budas GR, Boehm M, Kojonazarov B, <i> et al.</i>: ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension. <i>Am J Respir Crit Care Med.</i> 2018; <b>197</b>(3): 37385. <a target=xrefwindow id=d31667e2095 href="http://www.ncbi.nlm.nih.gov/pubmed/28910144">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2098 href="http://dx.doi.org/10.1164/rccm.201703-0502OC">Publisher Full Text </a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a name=d31667e2107 class=n-a></a>Lu HI, Huang TH, Sung PH, <i> et al.</i>: Administration of antioxidant peptide SS-31 attenuates transverse aortic constriction-induced pulmonary arterial hypertension in mice. <i>Acta Pharmacol Sin.</i> 2016; <b>37</b>(5): 589603. <a target=xrefwindow id=d31667e2118 href="http://www.ncbi.nlm.nih.gov/pubmed/27063219">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2121 href="http://dx.doi.org/10.1038/aps.2015.162">Publisher Full Text </a> | <a target=xrefwindow id=d31667e2125 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4857546">Free Full Text </a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a name=d31667e2134 class=n-a></a>Shimoda LA, Manalo DJ, Sham JS, <i> et al.</i>: Partial HIF-1alpha deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia. <i>Am J Physiol Lung Cell Mol Physiol.</i> 2001; <b>281</b>(1): L2028. <a target=xrefwindow id=d31667e2145 href="http://www.ncbi.nlm.nih.gov/pubmed/11404263">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2148 href="http://dx.doi.org/10.1152/ajplung.2001.281.1.L202">Publisher Full Text </a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a name=d31667e2157 class=n-a></a>Brusselmans K, Compernolle V, Tjwa M, <i> et al.</i>: Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. <i>J Clin Invest.</i> 2003; <b>111</b>(10): 151927. <a target=xrefwindow id=d31667e2168 href="http://www.ncbi.nlm.nih.gov/pubmed/12750401">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2171 href="http://dx.doi.org/10.1172/JCI15496">Publisher Full Text </a> | <a target=xrefwindow id=d31667e2175 href="http://www.ncbi.nlm.nih.gov/pmc/articles/155039">Free Full Text </a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a name=d31667e2184 class=n-a></a>Hickey MM, Richardson T, Wang T, <i> et al.</i>: The von Hippel-Lindau Chuvash mutation promotes pulmonary hypertension and fibrosis in mice. <i>J Clin Invest.</i> 2010; <b>120</b>(3): 82739. <a target=xrefwindow id=d31667e2195 href="http://www.ncbi.nlm.nih.gov/pubmed/20197624">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2198 href="http://dx.doi.org/10.1172/JCI36362">Publisher Full Text </a> | <a target=xrefwindow id=d31667e2202 href="http://www.ncbi.nlm.nih.gov/pmc/articles/2827942">Free Full Text </a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d31667e2211 class=n-a></a>Rhodes CJ, Howard LS, Busbridge M, <i> et al.</i>: Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights. <i>J Am Coll Cardiol.</i> 2011; <b>58</b>(3): 3009. <a target=xrefwindow id=d31667e2222 href="http://www.ncbi.nlm.nih.gov/pubmed/21737024">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2225 href="http://dx.doi.org/10.1016/j.jacc.2011.02.057">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d31667e2235 class=n-a></a>Viethen T, Gerhardt F, Dumitrescu D, <i> et al.</i>: Ferric carboxymaltose improves exercise capacity and quality of life in patients with pulmonary arterial hypertension and iron deficiency: a pilot study. <i>Int J Cardiol.</i> 2014; <b>175</b>(2): 2339. <a target=xrefwindow id=d31667e2246 href="http://www.ncbi.nlm.nih.gov/pubmed/24880481">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2249 href="http://dx.doi.org/10.1016/j.ijcard.2014.04.233">Publisher Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d31667e2258 class=n-a></a>Ruiter G, Manders E, Happ CM, <i> et al.</i>: Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiency. <i>Pulm Circ.</i> 2015; <b>5</b>(3): 46672. <a target=xrefwindow id=d31667e2269 href="http://www.ncbi.nlm.nih.gov/pubmed/26401247">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2272 href="http://dx.doi.org/10.1086/682217">Publisher Full Text </a> | <a target=xrefwindow id=d31667e2276 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4556497">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732741863"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d31667e2285 class=n-a></a>MacLean MMR: The serotonin hypothesis in pulmonary hypertension revisited: targets for novel therapies (2017 Grover Conference Series). <i>Pulm Circ.</i> 2018; <b>8</b>(2): 2045894018759125. <a target=xrefwindow id=d31667e2293 href="http://www.ncbi.nlm.nih.gov/pubmed/29468941">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2296 href="http://dx.doi.org/10.1177/2045894018759125">Publisher Full Text </a> | <a target=xrefwindow id=d31667e2299 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5826007">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732741863">F1000 Recommendation</a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727086322"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d31667e2312 class=n-a></a>Aiello RJ, Bourassa PA, Zhang Q, <i> et al.</i>: Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary Hypertension. <i>J Pharmacol Exp Ther.</i> 2017; <b>360</b>(2): 26779. <a target=xrefwindow id=d31667e2323 href="http://www.ncbi.nlm.nih.gov/pubmed/27927914">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2326 href="http://dx.doi.org/10.1124/jpet.116.237933">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727086322">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a name=d31667e2339 class=n-a></a>Said SI, Hamidi SA, Dickman KG, <i> et al.</i>: Moderate pulmonary arterial hypertension in male mice lacking the vasoactive intestinal peptide gene. <i>Circulation.</i> 2007; <b>115</b>(10): 12608. <a target=xrefwindow id=d31667e2350 href="http://www.ncbi.nlm.nih.gov/pubmed/17309917">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2353 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.106.681718">Publisher Full Text </a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a name=d31667e2362 class=n-a></a>Petkov V, Mosgoeller W, Ziesche R, <i> et al.</i>: Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension. <i>J Clin Invest.</i> 2003; <b>111</b>(9): 133946. <a target=xrefwindow id=d31667e2373 href="http://www.ncbi.nlm.nih.gov/pubmed/12727925">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2376 href="http://dx.doi.org/10.1172/JCI17500">Publisher Full Text </a> | <a target=xrefwindow id=d31667e2380 href="http://www.ncbi.nlm.nih.gov/pmc/articles/154449">Free Full Text </a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d31667e2390 class=n-a></a>Said SI: Vasoactive intestinal peptide in pulmonary arterial hypertension. <i>Am J Respir Crit Care Med.</i> 2012; <b>185</b>(7): 786; author reply 786. <a target=xrefwindow id=d31667e2398 href="http://www.ncbi.nlm.nih.gov/pubmed/22467806">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2401 href="http://dx.doi.org/10.1164/ajrccm.185.7.786">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726489937"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d31667e2410 class=n-a></a>van Campen JS, de Boer K, van de Veerdon MC, <i> et al.</i>: Bisoprolol in idiopathic pulmonary arterial hypertension: an explorative study. <i>Eur Respir J.</i> 2016; <b>48</b>(3): 78796. <a target=xrefwindow id=d31667e2421 href="http://www.ncbi.nlm.nih.gov/pubmed/27390285">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2424 href="http://dx.doi.org/10.1183/13993003.00090-2016">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726489937">F1000 Recommendation</a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d31667e2437 class=n-a></a>Farha S, Saygin D, Park MM, <i> et al.</i>: Pulmonary arterial hypertension treatment with carvedilol for heart failure: a randomized controlled trial. <i>JCI Insight.</i> 2017; <b>2</b>(16): pii: 95240. <a target=xrefwindow id=d31667e2448 href="http://www.ncbi.nlm.nih.gov/pubmed/28814664">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2451 href="http://dx.doi.org/10.1172/jci.insight.95240">Publisher Full Text </a> | <a target=xrefwindow id=d31667e2455 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5621927">Free Full Text </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d31667e2464 class=n-a></a>Tan WSD, Liao W, Zhou S, <i> et al.</i>: Targeting the renin-angiotensin system as novel therapeutic strategy for pulmonary diseases. <i>Curr Opin Pharmacol.</i> 2018; <b>40</b>: 917. <a target=xrefwindow id=d31667e2475 href="http://www.ncbi.nlm.nih.gov/pubmed/29288933">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2478 href="http://dx.doi.org/10.1016/j.coph.2017.12.002">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d31667e2487 class=n-a></a>Hemnes AR, Rathinasabapathy A, Austin EA, <i> et al.</i>: A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension. <i>Eur Respir J.</i> 2018; <b>51</b>(6): pii: 1702638. <a target=xrefwindow id=d31667e2498 href="http://www.ncbi.nlm.nih.gov/pubmed/29903860">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2501 href="http://dx.doi.org/10.1183/13993003.02638-2017">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a name=d31667e2510 class=n-a></a>Cavasin MA, Demos-Davies K, Horn TR, <i> et al.</i>: Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism. <i>Circ Res.</i> 2012; <b>110</b>(5): 73948. <a target=xrefwindow id=d31667e2521 href="http://www.ncbi.nlm.nih.gov/pubmed/22282194">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2524 href="http://dx.doi.org/10.1161/CIRCRESAHA.111.258426">Publisher Full Text </a> | <a target=xrefwindow id=d31667e2528 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3682822">Free Full Text </a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d31667e2538 class=n-a></a>Zhao L, Chen CN, Hajji N, <i> et al.</i>: Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid. <i>Circulation.</i> 2012; <b>126</b>(4): 45567. <a target=xrefwindow id=d31667e2549 href="http://www.ncbi.nlm.nih.gov/pubmed/22711276">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2552 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.112.103176">Publisher Full Text </a> | <a target=xrefwindow id=d31667e2556 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3799888">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d31667e2565 class=n-a></a>Bogaard HJ, Mizuno S, Hussaini AAA, <i> et al.</i>: Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats. <i>Am J Respir Crit Care Med.</i> 2011; <b>183</b>(10): 140210. <a target=xrefwindow id=d31667e2576 href="http://www.ncbi.nlm.nih.gov/pubmed/21297075">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2579 href="http://dx.doi.org/10.1164/rccm.201007-1106OC">Publisher Full Text </a></span></li><li><a name=ref-62 class=n-a></a><span class=label>62. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727774815"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d31667e2588 class=n-a></a>Boucherat O, Chabot S, Paulin R, <i> et al.</i>: HDAC6: A Novel Histone Deacetylase Implicated in Pulmonary Arterial Hypertension. <i>Sci Rep.</i> 2017; <b>7</b>(1): 4546. <a target=xrefwindow id=d31667e2599 href="http://www.ncbi.nlm.nih.gov/pubmed/28674407">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2602 href="http://dx.doi.org/10.1038/s41598-017-04874-4">Publisher Full Text </a> | <a target=xrefwindow id=d31667e2606 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5495763">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727774815">F1000 Recommendation</a></span></li><li><a name=ref-63 class=n-a></a><span class=label>63. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726760031"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d31667e2619 class=n-a></a>Chun HJ, Bonnet S, Chan SY: Translational Advances in the Field of Pulmonary Hypertension. Translating MicroRNA Biology in Pulmonary Hypertension. It Will Take More Than "miR" Words. <i>Am J Respir Crit Care Med.</i> 2017; <b>195</b>(2): 16778. <a target=xrefwindow id=d31667e2627 href="http://www.ncbi.nlm.nih.gov/pubmed/27648944">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2630 href="http://dx.doi.org/10.1164/rccm.201604-0886PP">Publisher Full Text </a> | <a target=xrefwindow id=d31667e2633 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5394787">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726760031">F1000 Recommendation</a></span></li><li><a name=ref-64 class=n-a></a><span class=label>64. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717397860"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d31667e2646 class=n-a></a>Caruso P, Dempsie Y, Stevens HC, <i> et al.</i>: A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples. <i>Circ Res.</i> 2012; <b>111</b>(3): 290300. <a target=xrefwindow id=d31667e2657 href="http://www.ncbi.nlm.nih.gov/pubmed/22715469">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2660 href="http://dx.doi.org/10.1161/CIRCRESAHA.112.267591">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717397860">F1000 Recommendation</a></span></li><li><a name=ref-65 class=n-a></a><span class=label>65. </span>&nbsp;<span class=citation><a name=d31667e2673 class=n-a></a>Deng L, Blanco FJ, Stevens H, <i> et al.</i>: MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension. <i>Circ Res.</i> 2015; <b>117</b>(10): 87083. <a target=xrefwindow id=d31667e2684 href="http://www.ncbi.nlm.nih.gov/pubmed/26311719">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2687 href="http://dx.doi.org/10.1161/CIRCRESAHA.115.306806">Publisher Full Text </a> | <a target=xrefwindow id=d31667e2691 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4620852">Free Full Text </a></span></li><li><a name=ref-66 class=n-a></a><span class=label>66. </span>&nbsp;<span class=citation><a name=d31667e2701 class=n-a></a>Ranchoux B, Meloche J, Paulin R, <i> et al.</i>: DNA Damage and Pulmonary Hypertension. <i>Int J Mol Sci.</i> 2016; <b>17</b>(6): pii: E990. <a target=xrefwindow id=d31667e2712 href="http://www.ncbi.nlm.nih.gov/pubmed/27338373">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2715 href="http://dx.doi.org/10.3390/ijms17060990">Publisher Full Text </a> | <a target=xrefwindow id=d31667e2719 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4926518">Free Full Text </a></span></li><li><a name=ref-67 class=n-a></a><span class=label>67. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718185665"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d31667e2728 class=n-a></a>Meloche J, Pflieger A, Vaillancourt M, <i> et al.</i>: Role for DNA damage signaling in pulmonary arterial hypertension. <i>Circulation.</i> 2014; <b>129</b>(7): 78697. <a target=xrefwindow id=d31667e2739 href="http://www.ncbi.nlm.nih.gov/pubmed/24270264">PubMed Abstract </a> | <a target=xrefwindow id=d31667e2742 href="http://dx.doi.org/10.1161/CIRCULATIONAHA.113.006167">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718185665">F1000 Recommendation</a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 24 Jul 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1128&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1128&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> Department of Medicine, Imperial College London, London, UK<br/> <p> <div class=margin-bottom> Martin R. Wilkins <br/> <span>Roles: </span> Writing  Original Draft Preparation </div> <div class=margin-bottom> Jurjan Aman <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> Lars Harbaum <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> Anna Ulrich <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> John Wharton <br/> <span>Roles: </span> Writing  Review & Editing </div> <div class=margin-bottom> Christopher J. Rhodes <br/> <span>Roles: </span> Writing  Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/7-1128/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 24 Jul 2018, 7:1128 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.14984.1">https://doi.org/10.12688/f1000research.14984.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden">  2018 Wilkins MR <em>et al</em>. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=16313 data-id=14984 data-downloads="" data-views="" data-scholar="10.12688/f1000research.14984.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/7-1128/v1/pdf?article_uuid=9ed08389-bb82-4d96-924c-47a8f19c2d0b" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.14984.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> Wilkins MR, Aman J, Harbaum L <em>et al.</em> Recent advances in pulmonary arterial hypertension [version 1; peer review: 2 approved] <i>F1000Research</i> 2018, <b>7</b>(F1000 Faculty Rev):1128 (<a href="https://doi.org/10.12688/f1000research.14984.1" target=_blank>https://doi.org/10.12688/f1000research.14984.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=14984 id=mobile-track-article-signin-14984 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/14984?target=/articles/7-1128"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=16313 /> <input name=articleId type=hidden value=14984 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>James E. Loyd</strong>, Department of Medicine, Vanderbilt University Medical Center, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>David B. Badesch</strong>, Pulmonary Hypertension Center, University of Colorado, USA </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> David Badesch serves on multiple advisory boards and steering committees, and as a consultant, to a number of biopharmaceutical companies developing products in the field, including Actelion, Gilead, United Therapeutics / Lung LLC, Arena, Belleraphon, Respira, Acceleron, and Complexa. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 24 Jul 2018</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/7-1128&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/7-1128&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=36797-36257></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=36796-36256></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/7-1128/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>24 Jul 18</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>James E. Loyd</strong>, Department of Medicine, Vanderbilt University Medical Center, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>David B. Badesch</strong>, Pulmonary Hypertension Center, University of Colorado, USA </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> David Badesch serves on multiple advisory boards and steering committees, and as a consultant, to a number of biopharmaceutical companies developing products in the field, including Actelion, Gilead, United Therapeutics / Lung LLC, Arena, Belleraphon, Respira, Acceleron, and Complexa. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/7-1128&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/7-1128/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in pulmonary arterial hypertension".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/7-1128/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/7-1128/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/7-1128/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('Wilkins MR et al.');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/7-1128/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/7-1128",
            templates : {
                twitter : "Recent advances in pulmonary arterial hypertension. Wilkins MR et al., published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/7-1128/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in pulmonary arterial hypertension", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in pulmonary arterial hypertension", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/14984/16313")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "16313");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "36256": 0,
                           "36257": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "53d0313a-cc04-4b45-908e-2df12c551a51";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1128.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1128.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/7-1128.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/7-1128.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/7-1128.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>